Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Cannabis The Next Big Thing As Investors Look To Weed Out A Profit

By CMC Markets (Michael Hewson)Stock MarketsOct 17, 2018 16:23
uk.investing.com/analysis/cannabis-the-next-big-thing-as-investors-look-to-weed-out-a-profit-200204231
Cannabis The Next Big Thing As Investors Look To Weed Out A Profit
By CMC Markets (Michael Hewson)   |  Oct 17, 2018 16:23
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

Until quite recently the words 'legal' and 'cannabis' were rarely seen in the same sentence, due to concerns over some of the more damaging effects the drug is reported to have on the cognitive functions of people who take it.

For those who support its mainstream legalisation, the argument went that it was no more harmful than alcohol or tobacco. Whether you believe that to be true or not, and there are plenty of arguments either way, the fact remains that cannabis, or marijuana, is slowly being recognised for some of its medicinal properties.

The drug has already been fully legalised in California, as well as a number of other US states, while today Canada has become the first G7 country to legalise recreational use of cannabis across the country.

The drug has also gained notoriety here in the UK in a number of high profile medical cases involving the use of cannabis oil in the treatment of severely ill children with the Home Secretary signing off dispensation by specialist doctors for the use of the oil.

Cannabis in the UK is currently a controlled drug under the Misuse of Drugs Act 1971, as well as the Misuse of Drugs Regulation Act 2001, which puts it under a category of substances with no medicinal value.

While there is no prospect of a significant change of tack from the UK government on how it views the legality or otherwise of cannabis, there does appear to be a growing recognition that certain parts of the plant can be harvested for medicinal uses, and legislation could well be changed in the future to reflect that.

This growing industry appears to be spawning a raft of start-up businesses keen to have a stake in what is likely to be a multi-billion dollar industry, but with that there still remains a high degree of resistance to its legalisation on a wider scale.

As with any spawning industry it will likely experience growing pains, as can be seen from the recent volatility seen in the share price movements of Tilray, a fledgling Canadian company that grows, cultivates and exports marijuana.

The price volatility seen in recent days has been astonishing for a company that for the moment has a limited market for its exports given that outside of Canada, Uruguay is the only other country where cannabis is legal. On a recent valuation the market values the business at an eye watering $10bn, a huge valuation for a business that on its last set of accounts turned over $20.5m.

Contrast that with GW Pharmaceuticals (NASDAQ:GWPH) which has been around since 1998 and has a market cap of $4.8bn and has been working on cannabinoid research for all of that time. It comes at the industry from the biotech side of the equation and as such is unlikely to see the same levels of volatility in its share price as it isn’t a cannabis producer.

Tilray (NASDAQ:TLRY) is not alone in looking to tap into what could become a huge market if other countries follow suit and legalise cannabis, even if only on a limited basis.

Other companies that have exposure to this sector include Canopy Growth Corp (TO:WEED), whose share price has more than doubled this year, Aurora Cannabis (TO:ACB), which has seen its share price double and then completely retrace over the same period, as well as Aphria (TO:APH) and Cronos Group (NASDAQ:CRON) whose share price movements have seen similar volatility.

While all of these companies can be viewed as unicorns, their valuations are all based on future potential and for something as controversial as cannabis, this makes them vulnerable to enormous price swings, given that none of them are currently profitable.

Last year we had Bitcoin and other cryptocurrencies that were flavour of the month, and attracted enormous interest, and we know that particular craze ended up with an awful lot of burnt fingers, as prices crashed at the beginning of this year.

This year it appears that investors are looking to weed out the next big investment opportunity in the form of medicinal cannabis.

While this could well be a lucrative sector for the canny trader and investor, it should also be subject to a health warning, as getting on the wrong side of a move could give the unwary a nasty case of withdrawal.

DISCLAIMER: CMC Markets is an execution only provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed.

No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.

Original post

Cannabis The Next Big Thing As Investors Look To Weed Out A Profit
 

Related Articles

Cannabis The Next Big Thing As Investors Look To Weed Out A Profit

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (3)
Mobile Voodoo Voodo
Mobile Voodoo Voodo Oct 17, 2018 19:32
Saved. See Saved Items.
This comment has already been saved in your Saved Items
the money of drugs is blood money
Andy Carr
Andy Carr Oct 17, 2018 18:37
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I'd tend to agree it will almost certainly become more like a commodity in the future however I think the pharmaceutical companies will be the first to reep the rewards. At the moment they are the middle man as well as the seller so they have the monopoly at the moment. If you see my point.
Mt Fi
Mt Fi Oct 17, 2018 17:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
do you think this is a bubble? the thing is why to invest in x and not y? seems there are so many of them. i see it as more like of a commodity trading in the future, rather than a cannaboid company
Andy Carr
Andy Carr Oct 17, 2018 17:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yeah
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Trading foreign exchange on margin carries a high level of risk, and may not be suitable for all investors. The inherent concept of such investments means that they are not suitable for the investor seeking income from such investments, and are only suitable for those who have the required experience and understand the market risks. You should carefully consider your investment objectives, level of experience, and seek advice from an independent financial advisor if you have any doubts.
Continue with Google
or
Sign up with Email